Skip to content

The Efficacy and Safety Study of Electro-acupuncture for Severe Chronic Functional Constipation

The Efficacy and Safety Study of Electro-acupuncture for Severe Chronic Functional Constipation - a Multi-center, Randomized Controlled Trial

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01726504
Enrollment
1075
Registered
2012-11-15
Start date
2012-10-31
Completion date
2014-12-31
Last updated
2016-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Constipation

Keywords

chronic functional constipation, electro-acupuncture, multi-center randomized controlled trial, efficacy, safety

Brief summary

The main purpose of this study is to evaluate efficacy of electro-acupuncture for severe functional constipation compared with sham acupuncture, used as placebo; the secondary purpose is to evaluate the safety and post-treatment effect of electro-acupuncture.

Detailed description

Chronic functional constipation is a common disease. To date there has not specific therapy on chronic functional constipation. Systematic reviews indicate that acupuncture is probably effective for the disease, but the evidence is limited. Recently, we have finished a multi-center clinical trial of individualized deep electro-acupuncture (EA) for chronic functional constipation (n=460, Registration ID: NCT00508482) which preliminarily showed EA was effective. This multi-center large-sample randomized controlled clinical trial of acupuncture for severe functional constipation is designed to confirm the efficacy and safety of EA. This project is conducted by Chinese experts, supported by the Chinese Government. The research result is expected to provide high quality evidence of EA for chronic functional constipation.

Interventions

DEVICEelectro-acupuncture

Procedure: electro-acupuncture; Points:Tianshu (ST25) Fujie(SP14), Shangjuxu (ST37).Pierced the skin, needles are inserted 30to70mm into bilateral ST25 and SP14 vertically until piercing the abdominal muscle layer.Electric stimulator is applied to bilateral ST25 and SP14 with dilatational wave, 10/50 Hz and electric current 0.1-1.0mA. The participant's abdominal muscle twitching mildly is the appropriate dose. Bilateral ST37 are inserted 25-30mm and then twirling lifting and thrusting for 3 times.Local sour and heavy feeling is appropriate dose. Steady small twirling lifting and thrusting 3 times in all. 30 min/per day/per session.During the 8 weeks treatment, the first 2 weeks,5 sessions per week, and 3 sessions per week in the rest 6 weeks,28 sessions for each patients in total.

Procedure:sham electro-acupuncture;Points:Sham Tianshu(ST25),sham Fujie(SP14),sham Shangjuxu (ST37).Sham points location:20mm away from ST25,middle of Spleen and Stomach Channel;30mm from SP14,middle of Spleen and Stomach Channel; one point beside ST37,middle of Stomach and Gallbladder Channel; Performance:The needle is inserted with needle of 0.30×25mm by 3-5mm. No twirling lifting and thrusting. The electric stimulator is applied to bilateral sham ST25 and sham SP14 with dilatational wave,10/50 Hz and electric current 0.5mA.The mental wire has been cut off with a same outlook as the treatment group.The electric stimulator is looked normal but with no current output. Length of Treatment and the treatment sessions are the same as treatment group.

Sponsors

Ministry of Science and Technology of the People´s Republic of China
CollaboratorOTHER_GOV
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* meeting the diagnosis of Rome III criteria for chronic functional constipation; * severe chronic constipation: two or fewer spontaneous complete bowel movements per week for more than 3 months; * 18-75 years old; * no use of medicine for constipation during the two weeks before enrollment (except rescue medication); * no acupuncture treatment for constipation in recent 3 months; * never joined any other trial in process in 3 months; * volunteered to join this research and signed the informed consent.

Exclusion criteria

* Irritable bowel syndrome (IBS) and constipation caused by endocrine, metabolic, nervous or postoperative diseases or drugs; * constipation accompanied by serious cardiovascular, hepatic, renal, or psychiatric disease, cognitive dysfunction or aphasia, or severe dystrophy affecting the cooperation for examination or treatment; * pregnant women or women in lactation period * constipation accompanied by abdominal aneurysm, hepatosplenomegaly, etcetera; * bleeding disorders, or regular anticoagulant drug users, such as warfarin and heparin, etcetera; * cardiac pacemaker carrier.

Design outcomes

Primary

MeasureTime frameDescription
the Change in Mean Weekly CSBMs During Weeks 1-8 Since TreatmentBaseline and weeks 1-8the change number in mean weekly CSBMs during weeks 1-8 since treatment compared with baseline.

Secondary

MeasureTime frameDescription
Changes in Mean Weekly CSBMs During Weeks 9-20Baseline and weeks 9-20The changed number in mean weekly average CSBMs during 9-20th weeks, compared with baseline.
Mean Weekly SBMs During Weeks 1-8Baseline and weeks 1-8The changed number in mean of weekly average SBMs (spontaneous bowel movement) during 8-week treatment, compared with baseline.
Mean Scores for Stool Consistency and Straining During Weeks 1-8Baseline and weeks 1-8average weekly stool consistency (Bristol Stool Scale) assessment of self-defecation during the 1-8weeks of treatment,compared with baseline. Bristol Stool Scale including 7-type, scored by 1 to 7 respectively.Type 1: Separate hard lumps, like nuts (hard to pass); Type 2: Sausage-shaped, but lumpy; Type 3: Like a sausage but with cracks on its surface; Type 4: Like a sausage or snake, smooth and soft; Type 5: Soft blobs with clear cut edges (passed easily); Type 6: Fluffy pieces with ragged edges, a mushy stool; Type 7: Watery, no solid pieces. Entirely liquid. Type 3, 4 are normal.
Change of Average Weekly Degree of Difficulty in Defecation From BaselineBaseline and weeks 1-8The degree of straining during self-defecation: The severity of straining is graded using a 4-point ordinal scale. 0 = not at all 1. = more straining than not 2. = a great deal 3. = an extreme amount, need finger manipulation to defecate average weekly degree of difficulty in self-defecation during 1-8weeks,compared with baseline
the Percentage of Participants With Three or More Weekly CSBMs1-20 weeksthe percentage of participants with three or more weekly CSBMs during weeks 1-8 and weeks 9-20
Number of Participants With Adverse Events Related to Acupuncture1-8 weeks
Mean of Weekly Frequency of Rescue Medicine and Other Defecation Assistances Used1-20 weeksRescue medicine for constipation during the trial will be recorded. For rescue medicine, any participants experiencing no bowel movements for 3 or more consecutive days during the whole trial period were allowed to use a 110 ml glycerol anal enema or 40-60 ml sorbitol anal enema as a rescue medicine with documentation in the stool diary.Other If a patient used other medicine, it should be also recorded in the diary.Only the frequences of rescue medicine and other medicine for constipation will be recorded in diary by patient. Weekly frequencies were combined across Weeks 1-8 and 9-20 per participant by averaged across all measurements.
The Number of Participants Using Rescue Medicine for Constipation1-20 weeks
Percentage of Weekly Frequency of Rescue Medicine and Other Defecation Assistances Used1-20 weeksRescue medicine for constipation during the trial will be recorded. For rescue medicine, any participants experiencing no bowel movements for 3 or more consecutive days during the whole trial period were allowed to use a 110 ml glycerol anal enema or 40-60 ml sorbitol anal enema as a rescue medicine with documentation in the stool diary.Other If a patient used other medicine, it should be also recorded in the diary.Only the frequences of rescue medicine and other medicine for constipation will be recorded in diary by patient. Weekly frequencies were combined across Weeks 1-8 and 9-20 per participant by averaged across all measurements.
Then Change Score of Health-related Quality of Life Via Patient-Assessment of Constipation Quality Of Life (PAC-QOL)baseline and the end of 8th weekPatient-Assessment of Constipation Quality Of Life(PAC-QOL) ranges are 28-140,and higher values represent a worse outcome.Subscales are summed to compute the total score. The changed score of PAC-QOL at week 8, compared with baseline.

Countries

China

Participant flow

Participants by arm

ArmCount
Electro-acupuncture
The acupuncture points are ST25, SP14,ST37. After sterilizing the skin, filiform needles are inserted 3 to 8 cm into bilateral ST25 and SP14 vertically and slowly without any manipulation until arrive the abdominal muscle layer(patients feel painful and acupuncturists feel touching hard). An electric stimulator (SDZ-V EA apparatus; Huatuo, China) is applied to bilateral ST25 and SP14 with a dilatational wave of 10/50 Hz and electric current between 0.1 and 1.0 mA with abdominal muscle twitching mildly indicating the appropriate dose. The bilateral ST37 is inserted 3cm - twirling, lifting and thrusting three times. A local sour and heavy feeling indicates the appropriate dose. Every session lasts for 30min/day. The participants are treated continuously for 8 weeks. During 8-week treatment the first 2 weeks,5 sessions per week, and 3 sessions per week in the rest 6 weeks,28 sessions for each patients in total.
536
Sham Electro-acupuncture
The acupuncture points are sham ST25, SP14, ST37. Sham location points are: about 2cm away from ST25,in the middle of the spleen and stomach channel; about 3 cm from SP14, in the middle of the spleen and stomach channel; one point beside ST37, in the middle of the stomach and gallbladder channel. The needle is inserted after sterilizing the skin by 1 to 1.5 cm, until the needle can be vertically fixed on the skin. No twirling lifting and thrusting manipulation is used. The sham electric stimulator (sham SDZ-V EA apparatus; Huatuo) is applied to the bilateral sham ST25 and sham SP14 with a dilatational wave of 10/50 Hz and electric current of 0.5 mA. The metal wire has been cut off inside to give the appearance of the real electric stimulator, with no current output. Length of treatment and the treatment sessions are the same as the treatment group sessions are the same as the treatment group.
539
Total1,075

Baseline characteristics

CharacteristicElectro-acupunctureSham Electro-acupunctureTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
89 Participants82 Participants171 Participants
Age, Categorical
Between 18 and 65 years
447 Participants457 Participants904 Participants
average number of times other measures were used
Others
0.08 number of times per week
STANDARD_DEVIATION 0.58
0.06 number of times per week
STANDARD_DEVIATION 0.43
0.07 number of times per week
STANDARD_DEVIATION 0.51
average number of times other measures were used
Rescue medicine
0.66 number of times per week
STANDARD_DEVIATION 1.47
0.62 number of times per week
STANDARD_DEVIATION 1.91
0.64 number of times per week
STANDARD_DEVIATION 1.71
Body-mass index22.32 kg/m^2
STANDARD_DEVIATION 3.04
22.75 kg/m^2
STANDARD_DEVIATION 3
22.54 kg/m^2
STANDARD_DEVIATION 3.03
Coexisting illness
Diabetes
11 participants10 participants21 participants
Coexisting illness
Digestive system disease
11 participants16 participants27 participants
Coexisting illness
Hypertension
41 participants39 participants80 participants
Coexisting illness
None
395 participants403 participants798 participants
Coexisting illness
Others
78 participants71 participants149 participants
Complete Spontaneous Bowel Movements (CSBMs) Per Week0.39 number of times
STANDARD_DEVIATION 0.62
0.42 number of times
STANDARD_DEVIATION 0.62
0.41 number of times
STANDARD_DEVIATION 0.62
Constipation duration (mon)130.81 month
STANDARD_DEVIATION 122.61
132.71 month
STANDARD_DEVIATION 127
131.76 month
STANDARD_DEVIATION 124.78
Race/Ethnicity, Customized
Han
519 participants526 participants1045 participants
Race/Ethnicity, Customized
Hui
8 participants9 participants17 participants
Race/Ethnicity, Customized
Man
5 participants2 participants7 participants
Race/Ethnicity, Customized
Miao
0 participants0 participants0 participants
Race/Ethnicity, Customized
other
3 participants0 participants3 participants
Race/Ethnicity, Customized
Wei
0 participants0 participants0 participants
Race/Ethnicity, Customized
Zhuang
1 participants2 participants3 participants
Score of Patient Assessment of Constipation Quality of Life(PAC-QOL)77.06 scores on a scale
STANDARD_DEVIATION 19.27
75.06 scores on a scale
STANDARD_DEVIATION 19.26
76.06 scores on a scale
STANDARD_DEVIATION 19.28
Sex: Female, Male
Female
415 Participants407 Participants822 Participants
Sex: Female, Male
Male
121 Participants132 Participants253 Participants
Spontaneous Bowel Movements (CSBMs) Per Week1.90 number of times
STANDARD_DEVIATION 1.34
2.02 number of times
STANDARD_DEVIATION 1.45
1.96 number of times
STANDARD_DEVIATION 1.4
Use of Other Measures by Participants
None
349 participants373 participants722 participants
Use of Other Measures by Participants
Others
17 participants19 participants36 participants
Use of Other Measures by Participants
Rescue medicine
170 participants147 participants317 participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
31 / 53424 / 538
serious
Total, serious adverse events
0 / 5340 / 538

Outcome results

Primary

the Change in Mean Weekly CSBMs During Weeks 1-8 Since Treatment

the change number in mean weekly CSBMs during weeks 1-8 since treatment compared with baseline.

Time frame: Baseline and weeks 1-8

ArmMeasureValue (MEAN)Dispersion
Electro-acupuncturethe Change in Mean Weekly CSBMs During Weeks 1-8 Since Treatment1.72 number of timesStandard Error 0.12
Sham Electro-acupuncturethe Change in Mean Weekly CSBMs During Weeks 1-8 Since Treatment0.82 number of timesStandard Error 0.13
Comparison: During the 8-week treatment period, the adjusted change from baseline in mean weekly CSBMs was 1.72 ± 0.12 (95% CI, 1.48 to 1.96) in the EA group and 0.82 ± 0.13 (95% CI, 0.58 to 1.07, P\<0.001) times more than that in the SA group.p-value: <0.001Mixed Models Analysis
Secondary

Change of Average Weekly Degree of Difficulty in Defecation From Baseline

The degree of straining during self-defecation: The severity of straining is graded using a 4-point ordinal scale. 0 = not at all 1. = more straining than not 2. = a great deal 3. = an extreme amount, need finger manipulation to defecate average weekly degree of difficulty in self-defecation during 1-8weeks,compared with baseline

Time frame: Baseline and weeks 1-8

ArmMeasureValue (MEAN)Dispersion
Electro-acupunctureChange of Average Weekly Degree of Difficulty in Defecation From Baseline-0.74 scores on a scaleStandard Error 0.03
Sham Electro-acupunctureChange of Average Weekly Degree of Difficulty in Defecation From Baseline-0.52 scores on a scaleStandard Error 0.03
Secondary

Changes in Mean Weekly CSBMs During Weeks 9-20

The changed number in mean weekly average CSBMs during 9-20th weeks, compared with baseline.

Time frame: Baseline and weeks 9-20

ArmMeasureValue (MEAN)Dispersion
Electro-acupunctureChanges in Mean Weekly CSBMs During Weeks 9-201.93 number of timesStandard Error 0.14
Sham Electro-acupunctureChanges in Mean Weekly CSBMs During Weeks 9-200.82 number of timesStandard Error 0.14
Secondary

Mean of Weekly Frequency of Rescue Medicine and Other Defecation Assistances Used

Rescue medicine for constipation during the trial will be recorded. For rescue medicine, any participants experiencing no bowel movements for 3 or more consecutive days during the whole trial period were allowed to use a 110 ml glycerol anal enema or 40-60 ml sorbitol anal enema as a rescue medicine with documentation in the stool diary.Other If a patient used other medicine, it should be also recorded in the diary.Only the frequences of rescue medicine and other medicine for constipation will be recorded in diary by patient. Weekly frequencies were combined across Weeks 1-8 and 9-20 per participant by averaged across all measurements.

Time frame: 1-20 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Electro-acupunctureMean of Weekly Frequency of Rescue Medicine and Other Defecation Assistances UsedWeek 1-8:Rescue medicine0.34 number of times per weekStandard Error 0.04
Electro-acupunctureMean of Weekly Frequency of Rescue Medicine and Other Defecation Assistances UsedWeek 1-8:others0.02 number of times per weekStandard Error 0.01
Electro-acupunctureMean of Weekly Frequency of Rescue Medicine and Other Defecation Assistances UsedWeek9-20:Rescue medicine0.25 number of times per weekStandard Error 0.04
Electro-acupunctureMean of Weekly Frequency of Rescue Medicine and Other Defecation Assistances UsedWeek 9-20:others0.02 number of times per weekStandard Error 0.01
Sham Electro-acupunctureMean of Weekly Frequency of Rescue Medicine and Other Defecation Assistances UsedWeek 9-20:others0.06 number of times per weekStandard Error 0.02
Sham Electro-acupunctureMean of Weekly Frequency of Rescue Medicine and Other Defecation Assistances UsedWeek 1-8:Rescue medicine0.52 number of times per weekStandard Error 0.06
Sham Electro-acupunctureMean of Weekly Frequency of Rescue Medicine and Other Defecation Assistances UsedWeek9-20:Rescue medicine0.37 number of times per weekStandard Error 0.05
Sham Electro-acupunctureMean of Weekly Frequency of Rescue Medicine and Other Defecation Assistances UsedWeek 1-8:others0.02 number of times per weekStandard Error 0.01
Secondary

Mean Scores for Stool Consistency and Straining During Weeks 1-8

average weekly stool consistency (Bristol Stool Scale) assessment of self-defecation during the 1-8weeks of treatment,compared with baseline. Bristol Stool Scale including 7-type, scored by 1 to 7 respectively.Type 1: Separate hard lumps, like nuts (hard to pass); Type 2: Sausage-shaped, but lumpy; Type 3: Like a sausage but with cracks on its surface; Type 4: Like a sausage or snake, smooth and soft; Type 5: Soft blobs with clear cut edges (passed easily); Type 6: Fluffy pieces with ragged edges, a mushy stool; Type 7: Watery, no solid pieces. Entirely liquid. Type 3, 4 are normal.

Time frame: Baseline and weeks 1-8

ArmMeasureValue (MEAN)Dispersion
Electro-acupunctureMean Scores for Stool Consistency and Straining During Weeks 1-80.87 score on a scaleStandard Error 0.05
Sham Electro-acupunctureMean Scores for Stool Consistency and Straining During Weeks 1-80.62 score on a scaleStandard Error 0.04
Secondary

Mean Weekly SBMs During Weeks 1-8

The changed number in mean of weekly average SBMs (spontaneous bowel movement) during 8-week treatment, compared with baseline.

Time frame: Baseline and weeks 1-8

ArmMeasureValue (MEAN)Dispersion
Electro-acupunctureMean Weekly SBMs During Weeks 1-82.30 number of timesStandard Error 0.1
Sham Electro-acupunctureMean Weekly SBMs During Weeks 1-81.28 number of timesStandard Error 0.1
Secondary

Number of Participants With Adverse Events Related to Acupuncture

Time frame: 1-8 weeks

ArmMeasureValue (NUMBER)
Electro-acupunctureNumber of Participants With Adverse Events Related to Acupuncture31 participants
Sham Electro-acupunctureNumber of Participants With Adverse Events Related to Acupuncture24 participants
Secondary

Percentage of Weekly Frequency of Rescue Medicine and Other Defecation Assistances Used

Rescue medicine for constipation during the trial will be recorded. For rescue medicine, any participants experiencing no bowel movements for 3 or more consecutive days during the whole trial period were allowed to use a 110 ml glycerol anal enema or 40-60 ml sorbitol anal enema as a rescue medicine with documentation in the stool diary.Other If a patient used other medicine, it should be also recorded in the diary.Only the frequences of rescue medicine and other medicine for constipation will be recorded in diary by patient. Weekly frequencies were combined across Weeks 1-8 and 9-20 per participant by averaged across all measurements.

Time frame: 1-20 weeks

ArmMeasureGroupValue (NUMBER)
Electro-acupuncturePercentage of Weekly Frequency of Rescue Medicine and Other Defecation Assistances UsedWeek 1-8:Rescue medicine28.92 percentage of participants
Electro-acupuncturePercentage of Weekly Frequency of Rescue Medicine and Other Defecation Assistances UsedWeek 1-8:others2.8 percentage of participants
Electro-acupuncturePercentage of Weekly Frequency of Rescue Medicine and Other Defecation Assistances UsedWeek9-20:Rescue medicine19.40 percentage of participants
Electro-acupuncturePercentage of Weekly Frequency of Rescue Medicine and Other Defecation Assistances UsedWeek 9-20:others2.24 percentage of participants
Sham Electro-acupuncturePercentage of Weekly Frequency of Rescue Medicine and Other Defecation Assistances UsedWeek 9-20:others3.15 percentage of participants
Sham Electro-acupuncturePercentage of Weekly Frequency of Rescue Medicine and Other Defecation Assistances UsedWeek 1-8:Rescue medicine33.95 percentage of participants
Sham Electro-acupuncturePercentage of Weekly Frequency of Rescue Medicine and Other Defecation Assistances UsedWeek9-20:Rescue medicine23.01 percentage of participants
Sham Electro-acupuncturePercentage of Weekly Frequency of Rescue Medicine and Other Defecation Assistances UsedWeek 1-8:others3.15 percentage of participants
Secondary

Then Change Score of Health-related Quality of Life Via Patient-Assessment of Constipation Quality Of Life (PAC-QOL)

Patient-Assessment of Constipation Quality Of Life(PAC-QOL) ranges are 28-140,and higher values represent a worse outcome.Subscales are summed to compute the total score. The changed score of PAC-QOL at week 8, compared with baseline.

Time frame: baseline and the end of 8th week

ArmMeasureValue (MEAN)Dispersion
Electro-acupunctureThen Change Score of Health-related Quality of Life Via Patient-Assessment of Constipation Quality Of Life (PAC-QOL)-25.65 score on a scaleStandard Error 2.39
Sham Electro-acupunctureThen Change Score of Health-related Quality of Life Via Patient-Assessment of Constipation Quality Of Life (PAC-QOL)-18.21 score on a scaleStandard Error 2.39
Secondary

The Number of Participants Using Rescue Medicine for Constipation

Time frame: 1-20 weeks

ArmMeasureGroupValue (NUMBER)
Electro-acupunctureThe Number of Participants Using Rescue Medicine for ConstipationWeek 1-8:Rescue medicine155 participants
Electro-acupunctureThe Number of Participants Using Rescue Medicine for ConstipationWeek 1-8:others15 participants
Electro-acupunctureThe Number of Participants Using Rescue Medicine for ConstipationWeek9-20:Rescue medicine104 participants
Electro-acupunctureThe Number of Participants Using Rescue Medicine for ConstipationWeek 9-20:others12 participants
Sham Electro-acupunctureThe Number of Participants Using Rescue Medicine for ConstipationWeek 9-20:others17 participants
Sham Electro-acupunctureThe Number of Participants Using Rescue Medicine for ConstipationWeek 1-8:Rescue medicine183 participants
Sham Electro-acupunctureThe Number of Participants Using Rescue Medicine for ConstipationWeek9-20:Rescue medicine124 participants
Sham Electro-acupunctureThe Number of Participants Using Rescue Medicine for ConstipationWeek 1-8:others17 participants
Secondary

the Percentage of Participants With Three or More Weekly CSBMs

the percentage of participants with three or more weekly CSBMs during weeks 1-8 and weeks 9-20

Time frame: 1-20 weeks

ArmMeasureGroupValue (NUMBER)
Electro-acupuncturethe Percentage of Participants With Three or More Weekly CSBMsWeek 1-831.34 percentage of participants
Electro-acupuncturethe Percentage of Participants With Three or More Weekly CSBMsWeek 9-2037.69 percentage of participants
Sham Electro-acupuncturethe Percentage of Participants With Three or More Weekly CSBMsWeek 1-812.06 percentage of participants
Sham Electro-acupuncturethe Percentage of Participants With Three or More Weekly CSBMsWeek 9-2014.10 percentage of participants

Source: ClinicalTrials.gov · Data processed: Mar 23, 2026